<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35958855</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>15</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>A bibliometric analysis of COVID-19 publications in neurology by using the visual mapping method.</ArticleTitle><Pagination><StartPage>937008</StartPage><MedlinePgn>937008</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">937008</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2022.937008</ELocationID><Abstract><AbstractText Label="BACKGROUND">The characteristic symptom of coronavirus disease 2019 (COVID-19) is respiratory distress, but neurological symptoms are the most frequent extra-pulmonary symptoms. This study aims to explore the current status and hot topics of neurology-related research on COVID-19 using bibliometric analysis.</AbstractText><AbstractText Label="METHODS">Publications regarding neurology and COVID-19 were retrieved from the Web of Science Core Collection (WoSCC) on March 28 2022. The Advanced search was conducted using "TS = ('COVID 19' or 'Novel Coronavirus 2019' or 'Coronavirus disease 2019' or '2019-nCOV' or 'SARS-CoV-2' or 'coronavirus-2') and TS = ('neurology'or 'neurological' or 'nervous system' or 'neurodegenerative disease' or 'brain' or 'cerebra' or 'nerve')". Microsoft Excel 2010 and VOSviewer were used to characterize the largest contributors, including the authors, journals, institutions, and countries. The hot topics and knowledge network were analyzed by CiteSpace and VOSviewer.</AbstractText><AbstractText Label="RESULTS">A total of 5,329 publications between 2020 and 2022 were retrieved. The United States, Italy, and the United Kingdom were three key contributors to this field. Harvard Medical School, the Tehran University of Medical Sciences, and the UCL Queen Square Institute of Neurology were the major institutions with the largest publications. Josef Finsterer from the University of S&#xe3;o Paulo (Austria) was the most prolific author. Tom Solomon from the University of Liverpool (UK) was the most cited author. <i>Neurological Sciences</i> and <i>Frontiers in Neurology</i> were the first two most productive journals, while <i>Journal of Neurology</i> held the first in terms of total citations and citations per publication. Cerebrovascular diseases, neurodegenerative diseases, encephalitis and encephalopathy, neuroimmune complications, neurological presentation in children, long COVID and mental health, and telemedicine were the central topics regarding the neurology-related research on COVID-19.</AbstractText><AbstractText Label="CONCLUSION">Neurology-related research on COVID-19 has attracted considerable attention worldwide. Research topics shifted from "morality, autopsy, and telemedicine" in 2020 to various COVID-19-related neurological symptoms in 2021, such as "stroke," "Alzheimer's disease," "Parkinson's disease," "Guillain-Barre syndrome," "multiple sclerosis," "seizures in children," and "long COVID." "Applications of telemedicine in neurology during COVID-19 pandemic," "COVID-19-related neurological complications and mechanism," and "long COVID" require further study.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Zhang, Li and Weng.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hypothalamic-Pituitary Research Center, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hydrocephalus Center, Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015706" MajorTopicYN="N">Bibliometrics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007492" MajorTopicYN="N" Type="Geographic">Iran</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Citespace</Keyword><Keyword MajorTopicYN="N">VOSviewer</Keyword><Keyword MajorTopicYN="N">bibliometric analysis</Keyword><Keyword MajorTopicYN="N">neurology</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>12</Day><Hour>3</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35958855</ArticleId><ArticleId IdType="pmc">PMC9362596</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2022.937008</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kwon S, Joshi AD, Lo CH, Drew DA, Nguyen LH, Guo CG, et al. . Association of social distancing and face mask use with risk of COVID-19. Nat Commun. (2021) 12:3737. 10.1038/s41467-021-24115-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24115-7</ArticleId><ArticleId IdType="pmc">PMC8213701</ArticleId><ArticleId IdType="pubmed">34145289</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkai I, Mayer MG, Hellmers LM, Ning B, Huang Z, Monjure CJ, et al. . Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates. Nat Commun. (2022) 13:1745. 10.1038/s41467-022-29440-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29440-z</ArticleId><ArticleId IdType="pmc">PMC8975902</ArticleId><ArticleId IdType="pubmed">35365631</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al. . Neurological associations of COVID-19. Lancet Neurol. (2020) 19:767&#x2013;83. 10.1016/S1474-4422(20)30221-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30221-0</ArticleId><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. . Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. (2020) 77:683&#x2013;90. 10.1001/jamaneurol.2020.1127</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL, et al. . Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. (2020) 7:875&#x2013;82. 10.2139/ssrn.3601761</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3601761</ArticleId><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. (2021) 374:n1648. 10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezzini A, Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat Rev Neurol. (2020) 16:636&#x2013;44. 10.1038/s41582-020-0398-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0398-3</ArticleId><ArticleId IdType="pmc">PMC7444680</ArticleId><ArticleId IdType="pubmed">32839585</ArticleId></ArticleIdList></Reference><Reference><Citation>Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the nervous system. Cell. (2020) 183:16&#x2013;27.e1. 10.1016/j.cell.2020.08.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.028</ArticleId><ArticleId IdType="pmc">PMC7437501</ArticleId><ArticleId IdType="pubmed">32882182</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Q, Lyu PH, Ma FC, Yao L, Zhang SJ. Global informetric perspective studies on translational medical research. BMC Med Inform Decis Mak. (2013) 13:77. 10.1186/1472-6947-13-77</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6947-13-77</ArticleId><ArticleId IdType="pmc">PMC3733606</ArticleId><ArticleId IdType="pubmed">23885955</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Sharma D, Rao S, Lim WM, Mangla SK. Past, present, and future of sustainable finance: insights from big data analytics through machine learning of scholarly research. Ann Oper Res. (2022) 1&#x2013;44. 10.1007/s10479-021-04410-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10479-021-04410-8</ArticleId><ArticleId IdType="pmc">PMC8723819</ArticleId><ArticleId IdType="pubmed">35002001</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan KIP, Ignacio KHD, Omar AT, 2nd, Khu KJO. Top 100 most cited neurologic and neurosurgical articles on COVID-19: a bibliometric analysis. World Neurosurg. (2022) 157:e137&#x2013;47. 10.1016/j.wneu.2021.09.118</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2021.09.118</ArticleId><ArticleId IdType="pmc">PMC8489273</ArticleId><ArticleId IdType="pubmed">34619402</ArticleId></ArticleIdList></Reference><Reference><Citation>Soytas M, Danacioglu YO, Boz MY, Horuz R, Albayrak S. COVID-19 and urology: a bibliometric analysis of the literature. Int J Clin Pract. (2021) 75:e14965. 10.1111/ijcp.14965</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14965</ArticleId><ArticleId IdType="pmc">PMC8646722</ArticleId><ArticleId IdType="pubmed">34626151</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasin O, Pasin T. A bibliometric analysis of rheumatology and COVID-19 researches. Clin Rheumatol. (2021) 40:4735&#x2013;40. 10.1007/s10067-021-05844-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-05844-y</ArticleId><ArticleId IdType="pmc">PMC8253236</ArticleId><ArticleId IdType="pubmed">34215906</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan X, Yan E, Cui M, Hua W. Examining the usage, citation, and diffusion patterns of bibliometric mapping software: a comparative study of three tools. J Informetr. (2018) 12:481&#x2013;93. 10.1016/j.joi.2018.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joi.2018.03.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Uzzi B. Scientific prize network predicts who pushes the boundaries of science. Proc Natl Acad Sci USA. (2018) 115:12608&#x2013;15. 10.1073/pnas.1800485115</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1800485115</ArticleId><ArticleId IdType="pmc">PMC6294901</ArticleId><ArticleId IdType="pubmed">30530666</ArticleId></ArticleIdList></Reference><Reference><Citation>You Y, Li W, Liu J, Li X, Fu Y, Ma X. Bibliometric review to explore emerging high-intensity interval training in health promotion: a new century picture. Front Public Health. (2021) 9:697633. 10.3389/fpubh.2021.697633</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.697633</ArticleId><ArticleId IdType="pmc">PMC8342813</ArticleId><ArticleId IdType="pubmed">34368063</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao T, Xia S, Zeng L, Lin G, Wei Q, Zhou W, et al. . A multicentre observational study on neonates exposed to SARS-CoV-2 in China: the Neo-SARS-CoV-2 Study protocol. BMJ Open. (2020) 10:e038004. 10.1136/bmjopen-2020-038004</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-038004</ArticleId><ArticleId IdType="pmc">PMC7380854</ArticleId><ArticleId IdType="pubmed">32699166</ArticleId></ArticleIdList></Reference><Reference><Citation>Hess DC, Eldahshan W, Rutkowski E. COVID-19-related stroke. Transl Stroke Res. (2020) 11:322&#x2013;5. 10.1007/s12975-020-00818-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12975-020-00818-9</ArticleId><ArticleId IdType="pmc">PMC7202903</ArticleId><ArticleId IdType="pubmed">32378030</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. . A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. (2020) 94:55&#x2013;8. 10.1016/j.ijid.2020.03.062</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.03.062</ArticleId><ArticleId IdType="pmc">PMC7195378</ArticleId><ArticleId IdType="pubmed">32251791</ArticleId></ArticleIdList></Reference><Reference><Citation>Louapre C, Collongues N, Stankoff B, Giannesini C, Papeix C, Bensa C, et al. . Clinical characteristics and outcomes in patients with coronavirus disease 2019 and multiple sclerosis. JAMA Neurol. (2020) 77:1079&#x2013;88. 10.1001/jamaneurol.2020.2581</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.2581</ArticleId><ArticleId IdType="pmc">PMC7320356</ArticleId><ArticleId IdType="pubmed">32589189</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanin L, Saraceno G, Panciani PP, Renisi G, Signorini L, Migliorati K, et al. . SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir. (2020) 162:1491&#x2013;4. 10.1007/s00701-020-04374-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00701-020-04374-x</ArticleId><ArticleId IdType="pmc">PMC7197630</ArticleId><ArticleId IdType="pubmed">32367205</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Sanguino C, Ausin B, Castellanos MA, Saiz J, Lopez-Gomez A, Ugidos C, et al. . Mental health consequences during the initial stage of the 2020 Coronavirus pandemic (COVID-19) in Spain. Brain Behav Immun. (2020) 87:172&#x2013;6. 10.1016/j.bbi.2020.05.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.05.040</ArticleId><ArticleId IdType="pmc">PMC7219372</ArticleId><ArticleId IdType="pubmed">32405150</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. (2020) 92:552&#x2013;5. 10.1002/jmv.25728</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25728</ArticleId><ArticleId IdType="pmc">PMC7228394</ArticleId><ArticleId IdType="pubmed">32104915</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivanti AJ, Vauloup-Fellous C, Prevot S, Zupan V, Suffee C, Do Cao J, et al. . Transplacental transmission of SARS-CoV-2 infection. Nat Commun. (2020) 11:3572. 10.1038/s41467-020-17436-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17436-6</ArticleId><ArticleId IdType="pmc">PMC7360599</ArticleId><ArticleId IdType="pubmed">32665677</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, et al. . Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. (2021) 24:168&#x2013;75. 10.1101/2020.06.04.135012</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.04.135012</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabi YM, Harthi A, Hussein J, Bouchama A, Johani S, Hajeer AH, et al. . Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV). Infection. (2015) 43:495&#x2013;501. 10.1007/s15010-015-0720-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-015-0720-y</ArticleId><ArticleId IdType="pmc">PMC4521086</ArticleId><ArticleId IdType="pubmed">25600929</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosravani H, Rajendram P, Notario L, Chapman MG, Menon BK. Protected code stroke: hyperacute stroke management during the coronavirus disease 2019 (COVID-19) pandemic. Stroke. (2020) 51:1891&#x2013;5. 10.1161/STROKEAHA.120.029838</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.120.029838</ArticleId><ArticleId IdType="pmc">PMC7258750</ArticleId><ArticleId IdType="pubmed">32233980</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki R, Yamasoba D, Kimura I, Wang L, Kishimoto M, Ito J, et al. . Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Nature. (2022) 603:700&#x2013;5. 10.1038/s41586-022-04462-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04462-1</ArticleId><ArticleId IdType="pmc">PMC8942852</ArticleId><ArticleId IdType="pubmed">35104835</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicek Korkmaz A, Altuntas S. A bibliometric analysis of COVID-19 publications in nursing by visual mapping method. J Nurs Manag. (2022). 16. 10.1111/jonm.13636</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jonm.13636</ArticleId><ArticleId IdType="pmc">PMC9115144</ArticleId><ArticleId IdType="pubmed">35429086</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu S, Wang X, Ma Y, Cheng H. Global research trends in pediatric COVID-19: a bibliometric analysis. Front Public Health. (2022) 10:798005. 10.3389/fpubh.2022.798005</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.798005</ArticleId><ArticleId IdType="pmc">PMC8888448</ArticleId><ArticleId IdType="pubmed">35252087</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai H, Lv Y, Xu Y, Wu Y, Zeng W, Wang T, et al. . Characteristic of Parkinson's disease with severe COVID-19: a study of 10 cases from Wuhan. J Neural Transm. (2021) 128:37&#x2013;48. 10.1007/s00702-020-02283-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-020-02283-y</ArticleId><ArticleId IdType="pmc">PMC7779096</ArticleId><ArticleId IdType="pubmed">33392827</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Zhang H, He Y, Qin C, Liu X, Liu M, et al. . Association between ischemic stroke and COVID-19 in China: a population-based retrospective study. Front Med. (2021) 8:792487. 10.3389/fmed.2021.792487</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.792487</ArticleId><ArticleId IdType="pmc">PMC8898959</ArticleId><ArticleId IdType="pubmed">35265632</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J, Scorza FA, Scorza C, Fiorini A. COVID-19 associated cranial nerve neuropathy: a systematic review. Bosn J Basic Med Sci. (2022) 22:39&#x2013;45. 10.17305/bjbms.2021.6341</Citation><ArticleIdList><ArticleId IdType="doi">10.17305/bjbms.2021.6341</ArticleId><ArticleId IdType="pmc">PMC8860318</ArticleId><ArticleId IdType="pubmed">34392827</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J, Scorza FA, Scorza CA, Fiorini AC. SARS-CoV-2 impairs vision. J Neuroophthalmol. (2021) 41:166&#x2013;9. 10.1097/WNO.0000000000001273</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNO.0000000000001273</ArticleId><ArticleId IdType="pubmed">33999887</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J. Exacerbating guillain-barre syndrome eight days after vector-based COVID-19 vaccination. Case Rep Infect Dis. (2021) 2021:3619131. 10.1155/2021/3619131</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/3619131</ArticleId><ArticleId IdType="pmc">PMC8123983</ArticleId><ArticleId IdType="pubmed">34055430</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J, Scorza FA. Guillain-Barre syndrome in 220 patients with COVID-19. Egypt J Neurol Psychiatr Neurosurg. (2021) 57:55. 10.1186/s41983-021-00310-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41983-021-00310-7</ArticleId><ArticleId IdType="pmc">PMC8094972</ArticleId><ArticleId IdType="pubmed">33967575</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovvuru S, Nalleballe K, Onteddu SR, Sharma R, Jasti M, Kapoor N, et al. . Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic. J Neurol Sci. (2021) 420:117230. 10.1016/j.jns.2020.117230</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117230</ArticleId><ArticleId IdType="pmc">PMC7837234</ArticleId><ArticleId IdType="pubmed">33256952</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Azorin D, Layos-Romero A, Porta-Etessam J, Membrilla JA, Caronna E, Gonzalez-Martinez A, et al. . Post-COVID-19 persistent headache: a multicentric 9-months follow-up study of 905 patients. Cephalalgia. (2022) 42:804&#x2013;809. 10.1177/03331024211068074</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03331024211068074</ArticleId><ArticleId IdType="pubmed">35166156</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Azorin D, Trigo J, Talavera B, Martinez-Pias E, Sierra A, Porta-Etessam J, et al. . Frequency and type of red flags in patients with Covid-19 and headache: a series of 104 hospitalized patients. Headache. (2020) 60:1664&#x2013;72. 10.1111/head.13927</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.13927</ArticleId><ArticleId IdType="pmc">PMC7436570</ArticleId><ArticleId IdType="pubmed">32790215</ArticleId></ArticleIdList></Reference><Reference><Citation>Talavera B, Garcia-Azorin D, Martinez-Pias E, Trigo J, Hernandez-Perez I, Valle-Penacoba G, et al. . Anosmia is associated with lower in-hospital mortality in COVID-19. J Neurol Sci. (2020) 419:117163. 10.1016/j.jns.2020.117163</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117163</ArticleId><ArticleId IdType="pmc">PMC7527278</ArticleId><ArticleId IdType="pubmed">33035870</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghmousavi S, Rezaei N. COVID-19 infection and stroke risk. Rev Neurosci. (2021) 32:341&#x2013;9. 10.1515/revneuro-2020-0066</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2020-0066</ArticleId><ArticleId IdType="pubmed">33580645</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamani R, Pouremamali R, Rezaei N. Central neuroinflammation in Covid-19: a systematic review of 182 cases with encephalitis, acute disseminated encephalomyelitis, and necrotizing encephalopathies. Rev Neurosci. (2021). 33:397&#x2013;412. 10.1515/revneuro-2021-0082</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2021-0082</ArticleId><ArticleId IdType="pubmed">34536341</ArticleId></ArticleIdList></Reference><Reference><Citation>Aliasin MM, Yazdanpanah N, Rezaei N. Neurological and neuropsychological adverse effects of SARS-CoV-2 vaccines - where do we stand? Rev Neurosci. (2022). 10.1515/revneuro-2022-0006</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2022-0006</ArticleId><ArticleId IdType="pubmed">35334195</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziff OJ, Ashton NJ, Mehta PR, Brown R, Athauda D, Heaney J, et al. . Amyloid processing in COVID-19-associated neurological syndromes. J Neurochem. (2022) 161:146&#x2013;57. 10.1111/jnc.15585</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15585</ArticleId><ArticleId IdType="pmc">PMC9115071</ArticleId><ArticleId IdType="pubmed">35137414</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel H, Ashton NJ, Dobson RJB, Andersson LM, Yilmaz A, Blennow K, et al. . Proteomic blood profiling in mild, severe and critical COVID-19 patients. Sci Rep. (2021) 11:6357. 10.1038/s41598-021-85877-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-85877-0</ArticleId><ArticleId IdType="pmc">PMC7973581</ArticleId><ArticleId IdType="pubmed">33737684</ArticleId></ArticleIdList></Reference><Reference><Citation>Eden A, Simren J, Price RW, Zetterberg H, Gisslen M. Neurochemical biomarkers to study CNS effects of COVID-19: a narrative review and synthesis. J Neurochem. (2021) 159:61&#x2013;77. 10.1111/jnc.15459</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15459</ArticleId><ArticleId IdType="pmc">PMC8420435</ArticleId><ArticleId IdType="pubmed">34170549</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. . Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. (2020) 7:611&#x2013;27. 10.1016/S2215-0366(20)30203-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30203-0</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. . Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. (2020) 87:18&#x2013;22. 10.1016/j.bbi.2020.03.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.03.031</ArticleId><ArticleId IdType="pmc">PMC7146689</ArticleId><ArticleId IdType="pubmed">32240762</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Song M. Visualizing a field of research: a methodology of systematic scientometric reviews. PLoS ONE. (2019) 14:e0223994. 10.1371/journal.pone.0223994</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0223994</ArticleId><ArticleId IdType="pmc">PMC6822756</ArticleId><ArticleId IdType="pubmed">31671124</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan WJ Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. . Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. (2020) 382:1708&#x2013;20. 10.1056/NEJMoa2002032</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Ntaios G, Michel P, Georgiopoulos G, Guo Y, Li W, Xiong J, et al. . Characteristics and outcomes in patients with COVID-19 and acute ischemic stroke: the global COVID-19 stroke registry. Stroke. (2020)51:e254&#x2212;8. 10.1161/STROKEAHA.120.031208</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.120.031208</ArticleId><ArticleId IdType="pmc">PMC7359900</ArticleId><ArticleId IdType="pubmed">32787707</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagris D, Papanikolaou A, Kvernland A, Korompoki E, Frontera J, Troxel A, et al. . COVID-19 and ischemic stroke. Eur J Neurol. (2021). 28:3826&#x2013;36. 10.1111/ene.15008</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15008</ArticleId><ArticleId IdType="pmc">PMC8444875</ArticleId><ArticleId IdType="pubmed">34224187</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaghi S, Ishida K, Torres J, Mac Grory B, Raz E, Humbert K, et al. . SARS-CoV-2 and stroke in a New York healthcare system. Stroke. (2020) 51:2002&#x2013;11. 10.1161/STROKEAHA.120.030335</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.120.030335</ArticleId><ArticleId IdType="pmc">PMC7258764</ArticleId><ArticleId IdType="pubmed">32432996</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweid A, Hammoud B, Bekelis K, Missios S, Tjoumakaris SI, Gooch MR, et al. . Cerebral ischemic and hemorrhagic complications of coronavirus disease 2019. Int J Stroke. (2020) 15:733&#x2013;42. 10.1177/1747493020937189</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1747493020937189</ArticleId><ArticleId IdType="pmc">PMC7534206</ArticleId><ArticleId IdType="pubmed">32501751</ArticleId></ArticleIdList></Reference><Reference><Citation>Mowla A, Shakibajahromi B, Shahjouei S, Borhani-Haghighi A, Rahimian N, Baharvahdat H, et al. . Cerebral venous sinus thrombosis associated with SARS-CoV-2; a multinational case series. J Neurol Sci. (2020) 419:117183. 10.1016/j.jns.2020.117183</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117183</ArticleId><ArticleId IdType="pmc">PMC7556283</ArticleId><ArticleId IdType="pubmed">33075595</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Agostino V, Caranci F, Negro A, Piscitelli V, Tuccillo B, Fasano F, et al. . A rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated to the COVID-19 vaccine administration. J Pers Med. (2021) 11:285. 10.3390/jpm11040285</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm11040285</ArticleId><ArticleId IdType="pmc">PMC8068274</ArticleId><ArticleId IdType="pubmed">33917902</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz JB, Berlit P, Diener HC, Gerloff C, Greinacher A, Klein C, et al. . COVID-19 vaccine-associated cerebral venous thrombosis in Germany. Ann Neurol. (2021) 90:627&#x2013;39. 10.1101/2021.04.30.21256383</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.04.30.21256383</ArticleId><ArticleId IdType="pmc">PMC8427115</ArticleId><ArticleId IdType="pubmed">34288044</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoessl AJ, Bhatia KP, Merello M. Movement disorders in the world of COVID-19. Mov Disord. (2020) 35:709&#x2013;10. 10.1002/mds.28069</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28069</ArticleId><ArticleId IdType="pubmed">32250468</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferini-Strambi L, Salsone M. COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable? J Neurol. (2021) 268:409&#x2013;19. 10.1007/s00415-020-10070-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10070-8</ArticleId><ArticleId IdType="pmc">PMC7372546</ArticleId><ArticleId IdType="pubmed">32696341</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkhratsky A, Li Q, Melino S, Melino G, Shi Y. Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases? Biol Direct. (2020) 15:28. 10.1186/s13062-020-00282-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13062-020-00282-3</ArticleId><ArticleId IdType="pmc">PMC7691955</ArticleId><ArticleId IdType="pubmed">33246479</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianchetti A, Rozzini R, Guerini F, Boffelli S, Ranieri P, Minelli G, et al. . Clinical presentation of COVID19 in dementia patients. J Nutr Health Aging. (2020) 24:560&#x2013;2. 10.1007/s12603-020-1389-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12603-020-1389-1</ArticleId><ArticleId IdType="pmc">PMC7227170</ArticleId><ArticleId IdType="pubmed">32510106</ArticleId></ArticleIdList></Reference><Reference><Citation>Motolese F, Magliozzi A, Puttini F, Rossi M, Capone F, Karlinski K, et al. . Parkinson's disease remote patient monitoring during the COVID-19 lockdown. Front Neurol. (2020) 11:567413. 10.3389/fneur.2020.567413</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.567413</ArticleId><ArticleId IdType="pmc">PMC7575750</ArticleId><ArticleId IdType="pubmed">33117262</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Prete E, Francesconi A, Palermo G, Mazzucchi S, Frosini D, Morganti R, et al. . Prevalence and impact of COVID-19 in Parkinson's disease: evidence from a multi-center survey in Tuscany region. J Neurol. (2021) 268:1179&#x2013;87. 10.1007/s00415-020-10002-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10002-6</ArticleId><ArticleId IdType="pmc">PMC7471534</ArticleId><ArticleId IdType="pubmed">32880722</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer S, Lersy F, Anheim M, Merdji H, Schenck M, Oesterle H, et al. . Neurologic and neuroimaging findings in patients with COVID-19: a retrospective multicenter study. Neurology. (2020) 95:e1868&#x2212;82. 10.1212/WNL.0000000000010112</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010112</ArticleId><ArticleId IdType="pubmed">32680942</ArticleId></ArticleIdList></Reference><Reference><Citation>Meppiel E, Peiffer-Smadja N, Maury A, Bekri I, Delorme C, Desestret V, et al. . Neurologic manifestations associated with COVID-19: a multicentre registry. Clin Microbiol Infect. (2021) 27:458&#x2013;66. 10.1101/2020.07.15.20154260</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.15.20154260</ArticleId><ArticleId IdType="pmc">PMC7661948</ArticleId><ArticleId IdType="pubmed">33189873</ArticleId></ArticleIdList></Reference><Reference><Citation>McLean NA, Popescu BF, Gordon T, Zochodne DW, Verge VM. Delayed nerve stimulation promotes axon-protective neurofilament phosphorylation, accelerates immune cell clearance and enhances remyelination in vivo in focally demyelinated nerves. PLoS ONE. (2014) 9:e110174. 10.1371/journal.pone.0110174</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0110174</ArticleId><ArticleId IdType="pmc">PMC4195712</ArticleId><ArticleId IdType="pubmed">25310564</ArticleId></ArticleIdList></Reference><Reference><Citation>Ottaviani D, Boso F, Tranquillini E, Gapeni I, Pedrotti G, Cozzio S, et al. . Early Guillain-Barre syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital. Neurol Sci. (2020) 41:1351&#x2013;4. 10.1007/s10072-020-04449-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04449-8</ArticleId><ArticleId IdType="pmc">PMC7216127</ArticleId><ArticleId IdType="pubmed">32399950</ArticleId></ArticleIdList></Reference><Reference><Citation>Uncini A, Vallat JM, Jacobs BC. Guillain-Barre syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic. J Neurol Neurosurg Psychiatry. (2020) 91:1105&#x2013;10. 10.1136/jnnp-2020-324491</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-324491</ArticleId><ArticleId IdType="pubmed">32855289</ArticleId></ArticleIdList></Reference><Reference><Citation>Loonstra FC, Hoitsma E, van Kempen ZL, Killestein J, Mostert JP. COVID-19 in multiple sclerosis: the Dutch experience. Mult Scler. (2020) 26:1256&#x2013;60. 10.1177/1352458520942198</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458520942198</ArticleId><ArticleId IdType="pmc">PMC7493197</ArticleId><ArticleId IdType="pubmed">32662742</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Raventos B, Roel E, Pistillo A, Martinez-Hernandez E, Delmestri A, et al. . Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis. BMJ. (2022) 376:e068373. 10.1136/bmj-2021-068373</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068373</ArticleId><ArticleId IdType="pmc">PMC8924704</ArticleId><ArticleId IdType="pubmed">35296468</ArticleId></ArticleIdList></Reference><Reference><Citation>Logunov DY, Dolzhikova IV, Zubkova OV, Tukhvatullin AI, Shcheblyakov DV, Dzharullaeva AS, et al. . Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia. Lancet. (2020) 396:887&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7471804</ArticleId><ArticleId IdType="pubmed">32896291</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. (2021) 38:101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Duarte A, Rivera-Izquierdo M, Guerrero-Fernandez de Alba I, Perez-Contreras M, Fernandez-Martinez NF, Ruiz-Montero R, et al. . Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study. BMC Med. (2021) 19:129. 10.1186/s12916-021-02003-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02003-7</ArticleId><ArticleId IdType="pmc">PMC8134820</ArticleId><ArticleId IdType="pubmed">34011359</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardo MDM, Foppiani A, Peretti GM, Mangiavini L, Battezzati A, Bertoli S, et al. . Long-term coronavirus disease 2019 complications in inpatients and outpatients: a one-year follow-up cohort study. Open Forum Infect Dis. (2021) 8:ofab384. 10.1093/ofid/ofab384</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab384</ArticleId><ArticleId IdType="pmc">PMC8344801</ArticleId><ArticleId IdType="pubmed">34386546</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, Bitna H, Kim SW, Chang HH, Kwon KT, Bae S, et al. . Post-acute COVID-19 syndrome in patients after 12 months from COVID-19 infection in Korea. BMC Infect Dis. (2022) 22:93. 10.1186/s12879-022-07062-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07062-6</ArticleId><ArticleId IdType="pmc">PMC8793328</ArticleId><ArticleId IdType="pubmed">35086489</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MS, Kristiansen MF, Hanusson KD, Foldbo BM, Danielsen ME, Steig BA, et al. . Prevalence of long COVID in a national cohort: longitudinal measures from disease onset until 8 months follow up. Int J Infect Dis. (2022). 122:437&#x2013;41. 10.1016/j.ijid.2022.06.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.06.031</ArticleId><ArticleId IdType="pmc">PMC9222150</ArticleId><ArticleId IdType="pubmed">35753603</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, et al. . Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. Clin Med. (2021) 21:e63&#x2013;7. 10.7861/clinmed.2020-0896</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Newell KL, Waickman AT. Inflammation, immunity, and antigen persistence in post-acute sequelae of SARS-CoV-2 infection. Curr Opin Immunol. (2022) 77:102228. 10.1016/j.coi.2022.102228</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2022.102228</ArticleId><ArticleId IdType="pmc">PMC9127180</ArticleId><ArticleId IdType="pubmed">35724449</ArticleId></ArticleIdList></Reference><Reference><Citation>Kompaniyets L, Agathis NT, Nelson JM, Preston LE, Ko JY, Belay B, et al. . Underlying medical conditions associated with severe COVID-19 illness among children. JAMA Netw Open. (2021) 4:e2111182. 10.1001/jamanetworkopen.2021.11182</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11182</ArticleId><ArticleId IdType="pmc">PMC8185607</ArticleId><ArticleId IdType="pubmed">34097050</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, et al. . Multisystem inflammatory syndrome in US children and adolescents N Engl J Med. (2020) 383:334&#x2212;46. 10.1056/NEJMoa2021680</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021680</ArticleId><ArticleId IdType="pmc">PMC7346765</ArticleId><ArticleId IdType="pubmed">32598831</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurd M, Hashavya S, Benenson S, Gilboa T. Seizures as the main presenting manifestation of acute SARS-CoV-2 infection in children. Seizure. (2021) 92:89&#x2013;93. 10.1016/j.seizure.2021.08.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.seizure.2021.08.017</ArticleId><ArticleId IdType="pmc">PMC8397499</ArticleId><ArticleId IdType="pubmed">34481322</ArticleId></ArticleIdList></Reference><Reference><Citation>Dilber B, Aydin ZGG, Yesilbas O, Sag E, Aksoy NK, Gundogmus F, et al. . Neurological manifestations of pediatric acute COVID infections: a single center experience. J Trop Pediatr. (2021) 67:fmab062. 10.1093/tropej/fmab062</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/tropej/fmab062</ArticleId><ArticleId IdType="pmc">PMC8344731</ArticleId><ArticleId IdType="pubmed">34254129</ArticleId></ArticleIdList></Reference><Reference><Citation>Davico C, Marcotulli D, Lux C, Calderoni D, Terrinoni A, Di Santo F, et al. . Where have the children with epilepsy gone? An observational study of seizure-related accesses to emergency department at the time of COVID-19. Seizure. (2020) 83:38&#x2013;40. 10.1016/j.seizure.2020.09.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.seizure.2020.09.025</ArticleId><ArticleId IdType="pmc">PMC7534601</ArticleId><ArticleId IdType="pubmed">33080483</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanigasinghe J, Jayawickrama A, Hewawitharana G, Munasinghe J, Weeraratne CT, Ratnayake P, et al. . Experience during COVID-19 lockdown and self-managing strategies among caregivers of children with epilepsy: a study from low middle income country. Seizure. (2021) 84:112&#x2013;5. 10.1016/j.seizure.2020.12.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.seizure.2020.12.001</ArticleId><ArticleId IdType="pmc">PMC10188295</ArticleId><ArticleId IdType="pubmed">33321430</ArticleId></ArticleIdList></Reference><Reference><Citation>Panda PK, Dawman L, Panda P, Sharawat IK. Feasibility and effectiveness of teleconsultation in children with epilepsy amidst the ongoing COVID-19 pandemic in a resource-limited country. Seizure. (2020) 81:29&#x2013;35. 10.1016/j.seizure.2020.07.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.seizure.2020.07.013</ArticleId><ArticleId IdType="pmc">PMC7368411</ArticleId><ArticleId IdType="pubmed">32712376</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair PP, Aghoram R, Thomas B, Bharadwaj B, Chinnakali P. Video teleconsultation services for persons with epilepsy during COVID-19 pandemic: an exploratory study from public tertiary care hospital in Southern India on feasibility, satisfaction, and effectiveness. Epilepsy Behav. (2021) 117:107863. 10.1016/j.yebeh.2021.107863</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yebeh.2021.107863</ArticleId><ArticleId IdType="pmc">PMC9760560</ArticleId><ArticleId IdType="pubmed">33677363</ArticleId></ArticleIdList></Reference><Reference><Citation>Wechsler LR. Advantages and limitations of teleneurology. JAMA Neurol. (2015) 72:349&#x2013;54. 10.1001/jamaneurol.2014.3844</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.3844</ArticleId><ArticleId IdType="pubmed">25580942</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy B, Nowak RJ, Roda R, Khokhar B, Patwa HS, Lloyd T, et al. . Teleneurology during the COVID-19 pandemic: a step forward in modernizing medical care. J Neurol Sci. (2020) 414:116930. 10.1016/j.jns.2020.116930</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.116930</ArticleId><ArticleId IdType="pmc">PMC7241381</ArticleId><ArticleId IdType="pubmed">32460041</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossman SN, Han SC, Balcer LJ, Kurzweil A, Weinberg H, Galetta SL, et al. . Rapid implementation of virtual neurology in response to the COVID-19 pandemic. Neurology. (2020) 94:1077&#x2013;87. 10.1212/WNL.0000000000009677</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009677</ArticleId><ArticleId IdType="pubmed">32358217</ArticleId></ArticleIdList></Reference><Reference><Citation>Fasano A, Antonini A, Katzenschlager R, Krack P, Odin P, Evans AH, et al. . Management of advanced therapies in Parkinson's disease patients in times of humanitarian crisis: the COVID-19 experience. Mov Disord Clin Pract. (2020) 7:361&#x2013;72. 10.1002/mdc3.12965</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mdc3.12965</ArticleId><ArticleId IdType="pmc">PMC7197306</ArticleId><ArticleId IdType="pubmed">32373652</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok VCT, Pendlebury S, Wong A, Alladi S, Au L, Bath PM, et al. . Tackling challenges in care of Alzheimer's disease and other dementias amid the COVID-19 pandemic, now and in the future. Alzheimers Dement. (2020) 16:1571&#x2013;81. 10.1002/alz.12143</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12143</ArticleId><ArticleId IdType="pmc">PMC7436526</ArticleId><ArticleId IdType="pubmed">32789951</ArticleId></ArticleIdList></Reference><Reference><Citation>Rametta SC, Fridinger SE, Gonzalez AK, Xian J, Galer PD, Kaufman M, et al. . Analyzing 2,589 child neurology telehealth encounters necessitated by the COVID-19 pandemic. Neurology. (2020) 95:e1257&#x2013;66. 10.1212/WNL.0000000000010010</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010010</ArticleId><ArticleId IdType="pmc">PMC7538222</ArticleId><ArticleId IdType="pubmed">32518152</ArticleId></ArticleIdList></Reference><Reference><Citation>Teng T, Sareidaki DE, Chemaly N, Bar C, Coste-Zeitoun D, Kuchenbuch M, et al. . Physician and patient satisfaction with the switch to remote outpatient encounters in epilepsy clinics during the Covid-19 pandemic. Seizure. (2021) 91:60&#x2013;5. 10.1016/j.seizure.2021.05.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.seizure.2021.05.013</ArticleId><ArticleId IdType="pmc">PMC9525220</ArticleId><ArticleId IdType="pubmed">34098318</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marchi F, Contaldi E, Magistrelli L, Cantello R, Comi C, Mazzini L. Telehealth in neurodegenerative diseases: opportunities and challenges for patients and physicians. Brain Sci. (2021) 91:60&#x2013;65. 10.3390/brainsci11020237</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11020237</ArticleId><ArticleId IdType="pmc">PMC7917616</ArticleId><ArticleId IdType="pubmed">33668641</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Chen J, Liu J. Global trends and hot-spots in research on virtual simulation in nursing: a bibliometric analysis from 1999 to 2021. Front Public Health. (2022) 10:890773. 10.3389/fpubh.2022.890773</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.890773</ArticleId><ArticleId IdType="pmc">PMC9082269</ArticleId><ArticleId IdType="pubmed">35548068</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi X, Wang S, Wu Y, Li Q, Zhang T, Min K, et al. . A bibliometric analysis of the innate immune DNA sensing cGAS-STING pathway from 2013 to 2021. Front Immunol. (2022) 13:916383. 10.3389/fimmu.2022.916383</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.916383</ArticleId><ArticleId IdType="pmc">PMC9204223</ArticleId><ArticleId IdType="pubmed">35720348</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>